{"entity":{"type":"insider","cik":"0001362314","url":"/insider/0001362314","json_url":"/insider/0001362314.json","name":"Buatois Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":18,"first":"2010-08-18","last":"2016-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Buatois Eric","source":"filing","n_filings":18,"first_seen":"2010-08-18","last_seen":"2016-10-24"}],"transactions":[{"id":3125948,"accession":"0001144204-16-129201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-129201","line_url":"/filing/0001144204-16-129201","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VI L P; Mehra Anand; Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Sofinnova Management VI, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750683.0,"shares_display":"750,683","price_per_share":1.389,"price_display":"1.39","price_state":"stated","total_value":1042698.687,"total_display":"1,042,698.69","total_whole":"1,042,699","shares_owned_after":1134851.0,"shares_owned_after_display":"1,134,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-24","scope":"insider","n_lines":3},{"id":6785999,"accession":"0001181431-14-028521","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-14-028521","line_url":"/filing/0001181431-14-028521","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VI, L.L.C.; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Venture Affiliates VI LP; HEALY JAMES; POWELL MICHAEL; Mehra Anand","owner_display_name":"Sofinnova Management VI, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750683.0,"shares_display":"750,683","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":6005464.0,"total_display":"6,005,464.00","total_whole":"6,005,464","shares_owned_after":1859639.0,"shares_owned_after_display":"1,859,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider","n_lines":3},{"id":6673354,"accession":"0001181431-14-026638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-026638","line_url":"/filing/0001181431-14-026638#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Buatois Eric; Sofinnova Management VII, L.L.C.; SOFINNOVA VENTURE PARTNERS VII L P; HEALY JAMES","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8022.0,"shares_display":"8,022","price_per_share":25.8078,"price_display":"25.81","price_state":"stated","total_value":207030.1716,"total_display":"207,030.17","total_whole":"207,030","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-10","filed_date":"2014-07-11","scope":"insider"},{"id":6673351,"accession":"0001181431-14-026638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-026638","line_url":"/filing/0001181431-14-026638#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Buatois Eric; Sofinnova Management VII, L.L.C.; SOFINNOVA VENTURE PARTNERS VII L P; HEALY JAMES","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":24.0013,"price_display":"24.00","price_state":"stated","total_value":24001300.0,"total_display":"24,001,300.00","total_whole":"24,001,300","shares_owned_after":1566657.0,"shares_owned_after_display":"1,566,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-09","filed_date":"2014-07-11","scope":"insider"},{"id":6673077,"accession":"0001181431-14-023211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-023211","line_url":"/filing/0001181431-14-023211#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; POWELL MICHAEL; Buatois Eric; SOFINNOVA VENTURE PARTNERS VII L P","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417747.0,"shares_display":"417,747","price_per_share":27.7,"price_display":"27.70","price_state":"stated","total_value":11571591.9,"total_display":"11,571,591.90","total_whole":"11,571,592","shares_owned_after":1939474.0,"shares_owned_after_display":"1,939,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-06","scope":"insider"},{"id":6336279,"accession":"0001181431-14-021313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-021313","line_url":"/filing/0001181431-14-021313#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Buatois Eric; SOFINNOVA VENTURE PARTNERS VII L P; POWELL MICHAEL; Mehra Anand; HEALY JAMES; Sofinnova Management VII, L.L.C.","owner_display_name":"Buatois Eric","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":323932.0,"shares_display":"323,932","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5182912.0,"total_display":"5,182,912.00","total_whole":"5,182,912","shares_owned_after":2766657.0,"shares_owned_after_display":"2,766,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider"},{"id":6253594,"accession":"0001181431-14-010850","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-010850","line_url":"/filing/0001181431-14-010850#line-3","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"SOFINNOVA VENTURE PARTNERS VII L P; Sofinnova Management VII, L.L.C.; Buatois Eric; POWELL MICHAEL; HEALY JAMES","owner_display_name":"SOFINNOVA VENTURE PARTNERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23625.0,"shares_display":"23,625","price_per_share":30.02,"price_display":"30.02","price_state":"stated","total_value":709222.5,"total_display":"709,222.50","total_whole":"709,223","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-05","scope":"insider"},{"id":5259987,"accession":"0001181431-13-055655","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-055655","line_url":"/filing/0001181431-13-055655#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"HEALY JAMES; POWELL MICHAEL; SOFINNOVA VENTURE PARTNERS VII L P; Sofinnova Management VII, L.L.C.; Mehra Anand; Buatois Eric","owner_display_name":"HEALY JAMES","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":285000.0,"shares_display":"285,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2850000.0,"total_display":"2,850,000.00","total_whole":"2,850,000","shares_owned_after":3090589.0,"shares_owned_after_display":"3,090,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2013-10-30","scope":"insider"},{"id":4882080,"accession":"0001181431-13-040378","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-040378","line_url":"/filing/0001181431-13-040378","is_derivative":false,"issuer_cik":"0001211465","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001211465","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":391166.0,"shares_display":"391,166","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":2357322.7824,"total_display":"2,357,322.78","total_whole":"2,357,323","shares_owned_after":1025364.0,"shares_owned_after_display":"1,025,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider","n_lines":3},{"id":2089389,"accession":"0001181431-12-043353","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-12-043353","line_url":"/filing/0001181431-12-043353#line-9","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Buatois Eric; Sofinnova Management VII, L.L.C.; HEALY JAMES; SOFINNOVA VENTURE PARTNERS VII L P; POWELL MICHAEL","owner_display_name":"Buatois Eric","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":563000.0,"shares_display":"563,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5630000.0,"total_display":"5,630,000.00","total_whole":"5,630,000","shares_owned_after":2947221.0,"shares_owned_after_display":"2,947,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-31","filed_date":"2012-08-02","scope":"insider"},{"id":2437743,"accession":"0001181431-12-042070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-042070","line_url":"/filing/0001181431-12-042070#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"SOFINNOVA VENTURE PARTNERS VII L P; Buatois Eric; POWELL MICHAEL; HEALY JAMES; Sofinnova Management VII, L.L.C.","owner_display_name":"SOFINNOVA VENTURE PARTNERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":588236.0,"shares_display":"588,236","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":5294124.0,"total_display":"5,294,124.00","total_whole":"5,294,124","shares_owned_after":2271330.0,"shares_owned_after_display":"2,271,330","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2012-07-25","scope":"insider"},{"id":3372236,"accession":"0001181431-12-000394","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-000394","line_url":"/filing/0001181431-12-000394","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; POWELL MICHAEL; Sofinnova Management VI, L.L.C.; Sofinnova Venture Partners VI GmbH & Co. KG; SOFINNOVA VENTURE PARTNERS VI L P; Buatois Eric; Azan Alain","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":6.225,"price_display":"6.22","price_state":"stated","total_value":155625.0,"total_display":"155,625.00","total_whole":"155,625","shares_owned_after":3298684.0,"shares_owned_after_display":"3,298,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-03","scope":"insider","n_lines":3},{"id":9094638,"accession":"0001181431-11-061935","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":6.2242,"price_display":"6.22","price_state":"stated","total_value":155605.0,"total_display":"155,605.00","total_whole":"155,605","shares_owned_after":3319314.0,"shares_owned_after_display":"3,319,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider","n_lines":3},{"id":9094635,"accession":"0001181431-11-061935","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":6.5108,"price_display":"6.51","price_state":"stated","total_value":162770.0,"total_display":"162,770.00","total_whole":"162,770","shares_owned_after":3339944.0,"shares_owned_after_display":"3,339,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider","n_lines":3},{"id":8955111,"accession":"0001181431-11-020948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-020948","line_url":"/filing/0001181431-11-020948#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"POWELL MICHAEL; HEALY JAMES; Buatois Eric; Sofinnova Management VII, L.L.C.; SOFINNOVA VENTURE PARTNERS VII L P","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424900.0,"shares_display":"424,900","price_per_share":7.2502,"price_display":"7.25","price_state":"stated","total_value":3080609.98,"total_display":"3,080,609.98","total_whole":"3,080,610","shares_owned_after":8513388.0,"shares_owned_after_display":"8,513,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-29","filed_date":"2011-03-31","scope":"insider"},{"id":9131358,"accession":"0001181431-11-020426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-020426","line_url":"/filing/0001181431-11-020426#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; POWELL MICHAEL; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VII L P","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75100.0,"shares_display":"75,100","price_per_share":7.5011,"price_display":"7.50","price_state":"stated","total_value":563332.61,"total_display":"563,332.61","total_whole":"563,333","shares_owned_after":8938288.0,"shares_owned_after_display":"8,938,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-25","filed_date":"2011-03-28","scope":"insider"},{"id":9131357,"accession":"0001181431-11-020426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-020426","line_url":"/filing/0001181431-11-020426#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; POWELL MICHAEL; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VII L P","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":7.556,"price_display":"7.56","price_state":"stated","total_value":3778000.0,"total_display":"3,778,000.00","total_whole":"3,778,000","shares_owned_after":9013388.0,"shares_owned_after_display":"9,013,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-24","filed_date":"2011-03-28","scope":"insider"},{"id":9171255,"accession":"0001181431-11-017938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017938","line_url":"/filing/0001181431-11-017938#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"POWELL MICHAEL; Buatois Eric; SOFINNOVA VENTURE PARTNERS VII L P; Sofinnova Management VII, L.L.C.; HEALY JAMES","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":9513388.0,"shares_owned_after_display":"9,513,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-14","scope":"insider"},{"id":8903094,"accession":"0001181431-11-017543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-017543","line_url":"/filing/0001181431-11-017543#line-2","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; HEALY JAMES; POWELL MICHAEL; SOFINNOVA VENTURE PARTNERS VII L P; Buatois Eric","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":606300.0,"shares_display":"606,300","price_per_share":7.2576,"price_display":"7.26","price_state":"stated","total_value":4400282.88,"total_display":"4,400,282.88","total_whole":"4,400,283","shares_owned_after":11513388.0,"shares_owned_after_display":"11,513,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-11","scope":"insider"},{"id":8903093,"accession":"0001181431-11-017543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017543","line_url":"/filing/0001181431-11-017543#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; HEALY JAMES; POWELL MICHAEL; SOFINNOVA VENTURE PARTNERS VII L P; Buatois Eric","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30700.0,"shares_display":"30,700","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":222575.0,"total_display":"222,575.00","total_whole":"222,575","shares_owned_after":12119688.0,"shares_owned_after_display":"12,119,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-09","filed_date":"2011-03-11","scope":"insider"},{"id":8937584,"accession":"0001181431-11-014039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-014039","line_url":"/filing/0001181431-11-014039#line-1","is_derivative":false,"issuer_cik":"0000897448","issuer_name":"AMARIN CORP PLC\\UK","issuer_ticker":"AMRN","issuer_name_source":null,"issuer_url":"/issuer/0000897448","owner_cik":null,"owner_name":"Sofinnova Management VII, L.L.C.; POWELL MICHAEL; HEALY JAMES; SOFINNOVA VENTURE PARTNERS VII L P; Buatois Eric","owner_display_name":"Sofinnova Management VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363000.0,"shares_display":"363,000","price_per_share":8.1344,"price_display":"8.13","price_state":"stated","total_value":2952787.2,"total_display":"2,952,787.20","total_whole":"2,952,787","shares_owned_after":12150388.0,"shares_owned_after_display":"12,150,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-25","filed_date":"2011-03-01","scope":"insider"},{"id":9251751,"accession":"0001181431-10-042350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-042350","line_url":"/filing/0001181431-10-042350#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":null,"owner_name":"Buatois Eric; HEALY JAMES; SOFINNOVA VENTURE PARTNERS VII L P; Sofinnova Management VII, L.L.C.","owner_display_name":"Buatois Eric","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":830000.0,"shares_display":"830,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4150000.0,"total_display":"4,150,000.00","total_whole":"4,150,000","shares_owned_after":3615572.0,"shares_owned_after_display":"3,615,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS INC","url":"/issuer/0001267813","role":"Ten percent owner","n_filings":2,"first_seen":"2014-08-07","last_seen":"2016-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Ten percent owner","n_filings":3,"first_seen":"2013-10-30","last_seen":"2014-07-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001386858","name":"HYPERION THERAPEUTICS INC","url":"/issuer/0001386858","role":"Ten percent owner","n_filings":3,"first_seen":"2012-08-02","last_seen":"2014-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Ten percent owner","n_filings":1,"first_seen":"2013-07-17","last_seen":"2013-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-25","last_seen":"2012-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Ten percent owner","n_filings":2,"first_seen":"2011-12-23","last_seen":"2012-01-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000897448","name":"AMARIN CORP PLC\\UK","url":"/issuer/0000897448","role":"Ten percent owner","n_filings":5,"first_seen":"2011-03-01","last_seen":"2011-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Ten percent owner","n_filings":1,"first_seen":"2010-08-18","last_seen":"2010-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362314","retrieved_at":"2026-08-24T20:48:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}